March 2017 FDA Recall Ciclopirox Olamine by G & W Laboratories, Inc.
D-0636-2017 - Labeling

This Class III drug recall was voluntarily initiated by G & W Laboratories, Inc. on March 20, 2017 for the product Ciclopirox Olamine. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0636-2017

Reason for Recall
Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.
Initiated
03-20-2017
Reported
04-12-2017
Quantity
230,700 tubes

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
G & W Laboratories, Inc.
Nationwide in the USA and Puerto Rico
Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15), b) 30 g tubes (NDC 0713-0638-31), and c) 90 g tubes (NDC 0713-0638-18), Rx only, Manufactured by: G&W Laboratories, Inc., South Plainfeld, NJ 07080.

Batch or Lot Expiration Information

Lot# : a) 63800090, Exp 04/17; 63800095, Exp 11/17; 1000573, Exp 02/18; 1002560, Exp 06/18; b) 63800090, Exp 04/17; 63800092, Exp 07/17; 63800093, Exp 08/17; 63800095, Exp 11/17; 1000574, Exp 02/18; 1001772, Exp 05/18; c) 63800089, Exp 03/17; 63800091, Exp 07/17; 63800094, Exp 08/17; 1000842, Exp 01/18; 1000966, Exp 03/18; 1001771, Exp 05/18; 1002562, Exp 06/18.